Navigation Links
Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013

ociated with our dependence on third-party service providers to successfully conduct clinical trials within and outside the United States; our ability to achieve and maintain profitability and maintain sufficient cash resources; the extent to which the pharmaceutical and biotechnology industries are willing to in-license drug candidates for their product pipelines and to collaborate with and fund third parties on their drug discovery activities; our ability to out-license our proprietary candidates on favorable terms; and our ability to attract and retain experienced scientists and management. We are providing this information as of February 4, 2013. We undertake no duty to update any forward-looking statements to reflect the occurrence of events or circumstances after the date of such statements or of anticipated or unanticipated events that alter any assumptions underlying such statements.Array BioPharma Inc.Condensed Statements of Operations(Unaudited)(in thousands, except per share amounts)Three Months Ended December 31,Six Months Ended December 31,2012201120122011RevenueLicense and milestone revenue$
37,657Collaboration revenue4,3614,0337,7187,701Total revenue18,37723,22834,21045,358Operating expensesCost of revenue7,9096,26614,44812,711Research and development for proprietary programs13,94113,15027,47525,748General and administrative4,6103,7829,3907,502Total operating expenses26,46023,19851,31345,961Loss from operations(8,083)30(17,103)(603)Other income (expense)Interest income123249Interest expense(2,860)(3,836)(5,619)(6,792)Total other expense, net(2,848)(3,833)(5,595)(6,783)Net loss$
(7,386)Weighted average shares outstanding - basic and diluted105,40360,00499,00558,515Net loss per share - basic and diluted$
(0.13)Summary Balance Sheet Data
(in thousands) December 31,  June 30, 20122012C
SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
2. Maine Manufacturing, LLC Announces Global Distribution of FAST® Protein Array Products
3. Self-assembling nanorods: Berkeley Lab researchers obtain 1-, 2- and 3-D nanorod arrays and networks
4. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
5. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
6. Solar nanowire array may increase percentage of suns frequencies available for energy conversion
7. Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts
8. Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor
9. John A. Orwin Joins Array BioPharma Board Of Directors
10. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
11. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
Post Your Comments:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... 9, 2010 Federico Capasso, Robert L. Wallace Professor ... in Electrical Engineering at the Harvard School of Engineering ... Berthold Leibinger Zukunftspreis (the future prize), an international award ... laser light. The prize, consisting of 30,000, will ...
... future molecular devices, new display technologies, and "artificial muscles" ... a primary role. Rotaxanes, one ... that consist of a dumbell-shaped molecule whose rod section ... molecular "machines," with the ring moving along the rod ...
... July 6 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd.,(Nasdaq: DHRM ), ... and homecare medical products in China , announced,today that it has ... for RMB11 million (about $1.58 million ). , ... The patented ...
Cached Biology Technology:Laser pioneer Federico Capasso awarded Berthold Leibinger Zukunftspreis 2Study measures single-molecule machines in action 2Dehaier Medical Systems Signs $1.6 Million Oxygen-Chip Sales Contract 2Dehaier Medical Systems Signs $1.6 Million Oxygen-Chip Sales Contract 3Dehaier Medical Systems Signs $1.6 Million Oxygen-Chip Sales Contract 4
(Date:4/16/2014)... childhood, associated with structural changes in the hippocampus ... New research from UC Davis is exploring how ... Eventually, that could give insights into disorders that ... adolescence and affect memory, such as schizophrenia and ... the brain, the hippocampus plays a key role ...
(Date:4/16/2014)... Dr. Panagiotis Papatheodorou from the Institute of Experimental and ... have discovered the receptor responsible for smuggling the toxin ... cell. The TpeL toxin, which is formed by ... and food poisoning. It is very similar to the ... Clostridium . The toxins bind to surface molecules ...
(Date:4/15/2014)... neurobiologists have found that genetically modified neural stem cells ... mice with the symptoms and pathology of Alzheimer,s disease. ... Stem Cells Research and Therapy , and the approach ... models. , Alzheimer,s disease, one of the most ... the protein amyloid-beta in the brain in the form ...
Breaking Biology News(10 mins):How kids' brain structures grow as memory develops 2Gate for bacterial toxins found 2UCI study finds modified stem cells offer potential pathway to treat Alzheimer's disease 2
... adhesion are very important in fundamental research on ... have been extensively investigated during the last decade. ... have conventionally been used to block cell adhesion. ... reported that the purple membrane (PM) containing a ...
... have been awarded $3.1 million by the National Institute ... Health, to study and develop several new compounds that ... the unwanted side effects common with opiate drugs, such ... an associate professor in the Department of Molecular Therapeutics ...
... rapidly, so quickly identifying them can be crucial to ... can take hours and days. But not for much ... science and electrical engineering at the University of Tennessee, ... and Fisheries at the UT Institute of Agriculture Center ...
Cached Biology News:New function of a bacterial photoresponsive protein: Resisting adhesion of mammalian cells 2Scripps Florida scientists awarded $3 million to develop new, more effective pain treatments 2University of Tennessee researchers invent device to rapidly detect infectious disease 2
Sheep polyclonal to Salmonella Shoreditch ( Abpromise for all tested applications). Antigen: Native Salmonella shoreditch (Group D2)....
Rabbit polyclonal to ZA20D3 ( Abpromise for all tested applications). entrezGeneID: 54469 SwissProtID: Q6FIF0...
... Rabbit polyclonal to Oct6 ( Abpromise ... Synthetic peptide conjugated to KLH derived from ... (Note: the amino acid sequence is proprietary) ... .) Entrez Gene ID: ...
ATP-binding cassette sub-family D member 4 (Peroxisomal membrane protein 69) (PMP69) (Peroxisomal membrane protein 1-like) (PXMP1-L) (P70R). [Source:Uniprot/SWISSPROT;Acc:O14678] Antigen: Recombi...
Biology Products: